Skip to main content
. Author manuscript; available in PMC: 2017 May 11.
Published in final edited form as: Leukemia. 2016 Oct 31;31(5):1059–1068. doi: 10.1038/leu.2016.309

Figure 3.

Figure 3

Effect of CD33 expression levels on (A) overall survival and (B) relapse in GO versus no GO randomised AML patients

Forest plot analysis of 393 non-CBF patients assessable for GO vs no GO comparison. Patients were stratified into CD33 expression quartile using CD33-MFI and %CD33-positivity.